Canandaigua National Bank & Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$463K Sell
4,861
-67
-1% -$6.57K 0.04% 240
2025
Q3
$481K Buy
+4,928
New +$510K 0.04% 244
2023
Q4
Sell
-5,026
Closed -$265K 269
2023
Q3
$265K Sell
5,026
-4,354
-46% -$228K 0.04% 214
2023
Q2
$507K Sell
9,380
-6,247
-40% -$326K 0.08% 171
2023
Q1
$782K Buy
+15,627
New +$736K 0.13% 150
2020
Q1
$401K Buy
+12,275
New +$480K 0.08% 168

Other funds holding BSX

Canandaigua National Bank & Trust's BSX Position: Q4 2025 in Review

Canandaigua National Bank & Trust reduced its Boston Scientific (BSX) stake by 1.4% in Q4 2025, selling an estimated $6.57K and leaving 4,861 shares worth $463K. The position accounts for 0.04% of the portfolio, ranked #240.

Canandaigua National Bank & Trust first reported a position in BSX in Q1 2020 and has held it in 6 quarters since. The position peaked at $782K in Q1 2023. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Canandaigua National Bank & Trust held 4,861 shares of Boston Scientific worth $463K as of Q4 2025.
  • Canandaigua National Bank & Trust sold 67 Boston Scientific shares in Q4 2025, an estimated $6.57K.
  • Boston Scientific made up 0.04% of Canandaigua National Bank & Trust's portfolio in Q4 2025, its #240 holding.
  • Canandaigua National Bank & Trust first reported a position in Boston Scientific in Q1 2020 and has held it in 6 quarters since.
  • Canandaigua National Bank & Trust's Boston Scientific position peaked at $782K in Q1 2023.
  • 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Canandaigua National Bank & Trust's 13F filing for Q4 2025, filed 30 Jan 2026.